investors

PRESS RELEASES

Angion to Present Results from Multiple Preclinical and Health Economic Studies at the American Transplant Congress Virtual Meeting
Angion Announces Publication of ANG-3777 Phase 2 Results in the Scientific Journal – Transplantation
Angion Initiates Dosing In Phase 1 Clinical Trial Evaluating ANG-3070, A Dual-Kinase Inhibitor For The Treatment of Fibrotic Diseases
Angion Presents Data on the Impact and Burden of Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
see more

EVENTS

J.P. Morgan Healthcare Conference
see more

CORPORATE PRESENTATIONS

CATEGORIES